What technical signals does Samyang KCI (036670) have?

Samyang KCI current technical signals: no active technical signal.

Is Samyang KCI a cup-and-handle pattern?

No. Samyang KCI has no valid cup-and-handle signal right now.

What are Samyang KCI's financials and valuation?

Samyang KCI's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Samyang KCI

036670 · KOSDAQ

₩5,110-0.20%

2026-09-04 close

Samyang KCI last closed at ₩5,110 (-0.20%) on 2026-09-04. Signals today: VCP. Listed on KOSDAQ; price, financials and dividends update daily after market close.

Loading chart…

No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions

303 picks

Next-day win rate

50.7%

Avg next-day

-0.11%

vs market

-0.49%p

Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.

Trade plan

EntryAccount sizeStopTarget (optional)Risk per trade (%)

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

Overall: 화학 52/109 · top 47%

Factor composite · relative position in sector

PER 3.91 · PBR 0.49 — own-history percentile 100/100 · 100/100

Open self-history band

PER100/100

PBR100/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Annual dividend

Split-adjusted annual DPS history and available grade axes

Annual dividend (per share · split-adjusted) · as of 2025

Consistency

Growth

B+

Yield

Safety

A+

Reference indicatorView observed cut rates

Paid 24 consecutive years · Raised 0 consecutive years · Yield 4.89% (based on 2025 payment of 250원) · 3-year growth +7.7%

Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.

Financial safety

Reference indicatorAs of 2024

Safe zoneFinancial-metric reference signal

Altman Z'' zoneZ'' 13.97

Distress

Grey

Safe

The marker shows the current Z'' value within the displayed zones.

Altman Z'': 13.97
Beneish M-Score: -3.19
Sloan accrual: -7.04%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

6/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score6/9

Profitability

Positive ROAPass
Positive OCFPass
Improving ΔROAPass
Accruals (OCF > net income)Pass

Leverage & liquidity

Lower debtNot passed
Higher current ratioNot passed
No new sharesPass

Efficiency

Higher gross marginPass
Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Industry structure

KRAs of 2026-09-05

화학

This stock is in 화학: revenue rank 68 of 108, share 0.1%.

68 / 1080.1%revenue share

Who dominates this industry?

1LG화학31.9%
2롯데케미칼13.3%
3금호석유화학4.7%
4DL3.7%
5코오롱인더3.2%
6삼양케이씨아이0.1%

Concentration

DistributedCR3 49.9%

HHI 1,299108 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p: 8.84
Direction: 확대
Level: 보통
Years: 6

Value lens

P90/P10: 9.5
Median P/B: 0.68
Level: 넓음
n: 96

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin: 13.6%
Interest coverage: 240.1x
Return on equity (ROE): 12.4%

Operating margin −5pp

Tolerable

Interest coverageBase 240.1x152x

Return on equity (ROE)Base 12.4%8%

Revenue −15%

Tolerable

Interest coverageBase 240.1x204x

Return on equity (ROE)Base 12.4%10.7%

Interest rate +2pp

Tolerable

Interest coverageBase 240.1x36.1x

Return on equity (ROE)Base 12.4%12.3%

Interest coverage limit

Current margin 13.6pp

Interest coverage limit at an operating margin of 0.1%

Interest expense coverage threshold

Connections

AI-extracted related companies · for reference

Suppliers

삼양사Price comovement r=0.38 (1 year)삼양홀딩스Price comovement r=0.39 (1 year)

Customers

LG생활건강Price comovement r=0.14 (1 year)아모레퍼시픽Price comovement r=0.29 (1 year)애경산업Price comovement r=0.33 (1 year)한국콜마Price comovement r=0.31 (1 year)코스맥스Price comovement r=0.32 (1 year)코리아나화장품

Competitors

듀폰BASFEvonikAshland

Same theme

바이오솔루션Price comovement r=0.11 (1 year)콜마비앤에이치Price comovement r=0.18 (1 year)

🔗 See in the full market map →

Recent filings

Samyang KCI's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

About Samyang KCI

What technical signals does Samyang KCI (036670) have?: Samyang KCI current technical signals: no active technical signal.
Is Samyang KCI a cup-and-handle pattern?: No. Samyang KCI has no valid cup-and-handle signal right now.
What are Samyang KCI's financials and valuation?: Samyang KCI's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy